Diffuse Large B Cell Lymphoma - an overview | ScienceDirect Topics
Survival analysis in patients with diffuse large B-cell lymphoma... | Download Scientific Diagram
A: Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System - The ASCO Post
Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial - The Lancet Haematology
Ibrutinib improves diffuse large B-cell lymphoma survival - NCI
Emerging immunotherapy and strategies directly targeting B cells for the treatment of diffuse large B-cell lymphoma | Immunotherapy
Treatment resistance in diffuse large B-cell lymphoma | Leukemia
Frontiers | Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma: Changing Treatment Paradigms
Diffuse Large B-Cell Lymphoma | NEJM
Determining Prognosis for Patients With Diffuse Large B-Cell Lymphoma - Hematology Advisor
JCM | Free Full-Text | Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact
Prediction of Prognosis for Patients with Diffuse Large B-Cell Lymphoma Refractory to or in First Relapse After Initial R-CHOP Therapy: A Single-Institution Study | Anticancer Research
Figure 2 from Spanish Lymphoma Group (GELTAMO) guidelines for the diagnosis, staging, treatment, and follow-up of diffuse large B-cell lymphoma | Semantic Scholar
De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients | Haematologica
New Approaches to the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Overall survival of patients with diffuse large B-cell lymphoma after... | Download Scientific Diagram
Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role? | Haematologica
Biology Informs Treatment Choices in Diffuse Large B Cell Lymphoma: Trends in Cancer
The Korean Journal of Internal Medicine
A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in Asian patients treated in the Rituximab Era | Scientific Reports
Cancers | Free Full-Text | Monoclonal Antibodies in the Treatment of Diffuse Large B-Cell Lymphoma: Moving beyond Rituximab
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI - ScienceDirect
Evolution of therapy for limited stage diffuse large B-cell lymphoma | Blood Cancer Journal
A: Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System - The ASCO Post
Diffuse Large B-Cell Lymphoma | NEJM
